Vitamin E supplementation in pregnancy

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 3, 2015, Pages

  Rumbold, Alice ^a   Ota, Erika ^b   Hori, Hiroyuki ^b   Miyazaki, Celine ^c   Crowther, Caroline A ^a,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT;

ADVERSE OUTCOME; APGAR SCORE; BIRTH WEIGHT; BLEEDING; BRAIN HEMORRHAGE; CESAREAN SECTION; CHRONIC LUNG DISEASE; CONGENITAL MALFORMATION; ENCEPHALOMALACIA; GESTATIONAL AGE; HUMAN; HYPERBILIRUBINEMIA; INTRAUTERINE GROWTH RETARDATION; LUNG DYSPLASIA; MATERNAL MORBIDITY; MATERNAL MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN DEATH; OXIDATIVE STRESS; PERINATAL DEATH; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; REVIEW; SEPSIS; STILLBIRTH; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; ADVERSE EFFECTS; DIET SUPPLEMENTATION; FEMALE; META ANALYSIS; NEWBORN; PRE-ECLAMPSIA; PREGNANCY COMPLICATIONS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMALL FOR DATE INFANT;

ANTIOXIDANTS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN E;

EID: 84957646820     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004069.pub3     Document Type: Review

References (89)

1. Anthony J, Smith P, Mantel G, Johanson R. A randomised controlled trial of vitamin E supplementation in conservatively managed pre-eclamptic patients. 10th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8;Seattle, Washington, USA. 1996:193.
2. Beazley D, Ahokas R, Livingston J, Griggs M, Scroggs M, Sibai B. Effects of vitamin c and e supplementation on total antioxidant status (tas) and 8-isoprostane (ip) levels in women at high risk for preeclampsia [abstract]. American Journal of Obstetrics and Gynecology 2002;187(6 Pt 2):S76.
3. Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM. Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. American Journal of Obstetrics and Gynecology 2005; Vol. 192:520-1.
4. Beazley D, Livingston J, Kao L, Sibai B. Vitamin c and e supplementation in women at high risk for preeclampsia: a double-blind placebo controlled trial [abstract]. American Journal of Obstetrics and Gynecology 2002;187(6 Pt 2):S216.
5. Borna S, Borna H, Daneshbodie B. Vitamins C and E in the latency period in women with preterm premature rupture of membranes. International Journal of Gynecology & Obstetrics 2005; Vol. 90:16-20.
6. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999;354(9181):810-6.
7. Chappell LC, Seed PT, Kelly FJ, Briley A, Hunt BJ, Charnock-Jones DS, et al. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. American Journal of Obstetrics and Gynecology 2002;187(3):777-84.
8. Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MM. Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. British Journal of Obstetrics and Gynaecology 1997;104(6):689-96.
9. Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MM. Placental malondialdehyde and glutathione levels in a controlled trial of antioxidant treatment in severe preeclampsia. Hypertension in pregnancy 1996;15(3):287-95.
10. Gungorduk K, Asicioglu O, Gungorduk OC, Yildirim G, Besimoglu B, Ark C. Does vitamin C and vitamin E supplementation prolong the latency period before delivery following the preterm premature rupture of membranes? a randomized controlled study. American Journal of Perinatology 2014;31(3):195-202.
11. Huria A, Gupta P, Kumar D, Sharma MK. Vitamin C and vitamin E supplementation in pregnant women at risk for pre eclampsia: a randomized controlled trial. Internet Journal of Health 2010; Vol. 10, issue 2.
12. Kalpdev A, Saha SC, Dhawan V. Vitamin C and E supplementation does not reduce the risk of superimposed PE in pregnancy. Hypertension in Pregnancy 2011;30(4):447-56.
13. Mahdy ZA, Siraj HH, Azwar MH, Wahab MA, Khaza'ai H, Mutalib MSA, et al. The role of palm oil vitamin E in the prevention of pregnancy-induced hypertension [abstract]. Hypertension in Pregnancy 2004; Vol. 23, issue Suppl 1:67.
14. Holmes V, Young I, Maresh M, Pearson D, Walker J, McCance D, et al. The diabetes and pre-eclampsia intervention trial (DAPIT) [abstract]. Hypertension in Pregnancy 2004;23(Suppl 1):68.
15. Holmes VA, Young IS, Maresh MJA, Pearson DWM, Walker JD, McCance D and the DAPIT Study Group. The diabetes and pre-eclampsia intervention trial. International Journal of Gynecology & Obstetrics 2004;87:66-71.
16. Holmes VA, Young IS, Patterson CC, Pearson DWM, Walker JD, Maresh MJA, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the Diabetes and Pre-Eclampsia Intervention Trial. Diabetes Care 2011;34(8):1683-8.
17. Johnston PC, Powell LA, McCance DR, Pogue K, McMaster C, Gilchrist S, et al. Placental protein tyrosine nitration and MAPK in type 1 diabetic pre-eclampsia: Impact of antioxidant vitamin supplementation. Journal of Diabetes & its Complications 2013;27(4):322-7.
18. McCance DR, Holmes VA, Maresh MJ, Patterson CC, Walker JD, Pearson DW, et al. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet 2010;376(9737):259-66.
19. Weissgerber TL, Gandley RE, Roberts JM, Patterson CC, Holmes VA, Young IS, et al. Haptoglobin phenotype, pre-eclampsia, and response to supplementation with vitamins C and E in pregnant women with type-1 diabetes. BJOG :an international journal of obstetrics and gynaecology 2013;120(10):1192-9.
20. Nasrolahi Sh, Alimohammady Sh, Zamani M. The effect of antioxidants (vitamin e and c) on preeclampsia in primiparous women. Journal of Gorgan University of Medical Sciences 2006; Vol. 8, issue 1:17-21.
21. Duckworth S, Shennan A, Chappell L, Seed P, Briley A. Effect of antioxidant supplementation on pre-labour rupture of the membranes. Archives of Disease in Childhood: Fetal and Neonatal Edition 2011;96:Fa75-Fa76.
22. Greenough A, Shaheen S, Shennan A, Seed P. Respiratory outcome in childhood of maternal vitamin C and E supplementation. American Journal of Respiratory and Critical Care Medicine 2009;179:A5975.
23. Greenough A, Shaheen SO, Shennan A, Seed PT, Poston L. Respiratory outcomes in early childhood following antenatal vitamin C and E supplementation. Thorax 2010;65(11):998-1003.
24. Manning L, Briley A, Poston L, Chappell L, Shennan A. Supplementation with vitamins C and E in pregnancy and liver function [abstract]. BJOG: an international journal of obstetrics and gynaecology 2007; Vol. 114, issue 8:1038.
25. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH, for the Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006; Vol. 367, issue 9517:1145-54.
26. Poston L, Shennan A, Maternal and Fetal Research Unit. Vitamins in pre-eclampsia (VIP). Maternal and Fetal Research Unit www.mfru.info/VIP.html (accessed 25 February 2004).
27. Shennan AH, Briley AL, Seed PT, Kelly FJ, Poston L. A randomised controlled trial (RCT) of vitamin C and E supplementation in high risk women to prevent pre-eclampsia (the VIP trial; on behalf of the VIP trial consortium) [abstract]. Journal of Obstetrics and Gynaecology 2006; Vol. 26, issue 1:S18-20.
28. Pressman EK, Cavanaugh JL, Mingione M, Norkus EP, Woods JR. Effects of maternal antioxidant supplementation on maternal and fetal antioxidant levels: a randomized, double-blind study. American Journal of Obstetrics and Gynecology 2003;189:1720-5.
29. Rivas-Echeverria CA, Echeverria Y, Molina L, Novoa D. Synergic use of aspirin, fish oil and vitamins C and E for the prevention of preeclampsia [abstract]. Hypertension in Pregnancy 2000;19(Suppl 1):30.
30. Gandley R, Abramovici A. Prenatal vitamin C and e supplementation is associated with a reduction in placental abruption and preterm birth in smokers. Pregnancy Hypertension 2012;2(3):331-2.
31. Hauth J, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Vitamin C and E supplementation to prevent preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology 2009; Vol. 201, issue 6 Suppl 1:S175-S176.
32. Hauth JC. Maternal insulin resistance and preeclampsia. American Journal of Obstetrics & Gynecology 2011;204(1 Suppl):S12.
33. Hauth JC, Clifton RG, Roberts JM, Myatt L, Spong CY, Leveno KJ, et al. Maternal insulin resistance and preeclampsia. American Journal of Obstetrics and Gynecology 2011;204(4):327.e1-327.e6.
34. Hauth JC, Clifton RG, Roberts JM, Spong CY, Myatt L, Leveno KJ, et al. Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trial. Obstetrics & Gynecology 2010;116(3):653-8.
35. NICHD MFMU Network. Combined antioxidants and preeclampsia prediction studies. http://www.bsc.gwu.edu/mfmu/projects/capps.cgi (accessed 1 September 2004).
36. National Institute of Child Health and Human Development (NICHD). Antioxidant therapy to prevent preeclampsia. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 14 June 2005) 2005.
37. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. New England Journal of Medicine 2010;362(14):1282-91. [PUBMED: 20375405]
38. Roberts JM, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). A randomized controlled trial of antioxidant vitamins to prevent serious complications associated with pregnancy related hypertension in low risk, nulliparous women. American Journal of Obstetrics and Gynecology 2008; Vol. 199, issue 6 Suppl 1:S4.
39. Weissgerber T, Gandley R. Risk of types of pregnancy associated hypertension according to haptoglobin phenotype. Reproductive Sciences 2011;18(3 Suppl 1):69A.
40. Weissgerber TL, Gandley RE, McGee PL, Spong CY, Myatt L, Leveno KJ, et al. Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse population. PLoS ONE 2013;8(4):e60479.
41. Crowther CA, Dekker G, Haslam R, Robinson J. Australian collaborative trial of supplements with vitamin C and vitamin E for the prevention of pre-eclampsia: a randomised trial. Personal Communication 2004.
42. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS. Australian collaborative trial of supplements (ACTS) with vitamin C and E for the prevention of pre-eclampsia - a randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3-6; Perth, Australia 2006:180.
43. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS, for the ACTS Study Group. Vitamins C and E and the risks of preeclampsia and perinatal complications. New England Journal of Medicine 2006; Vol. 354, issue 17:1796-806.
44. Sawhney H, Singhal S, Vasishta K, Majumbar S. Effect of vitamin E supplementation on lipid peroxide levels in preeclampsia [abstract]. XVI FIGO World Congress of Obstetrics & Gynecology; 2000 Sept 3-8; Washington DC, USA 2000;Book 5:31.
45. Shahraki AD. Effects of vitamin E, calcium carbonate and milk of magnesium on muscular cramps in pregnant women. Journal of Medical Sciences 2006; Vol. 6, issue 6:979-83.
46. Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, et al. The impact of prior preeclampsia on the risk of superimposed preeclampsia and other adverse pregnancy outcomes in patients with chronic hypertension. American Journal of Obstetrics and Gynecology 2011;204(4):345.e1-345.e6.
47. Spinnato II J, Freire S, Pinto e Silva JLP, Rudge M, Martins-Costa S, Koch M, et al. Antioxidant therapy and PROM. American Journal of Obstetrics and Gynecology 2007; Vol. 197, issue 6 Suppl 1:S196, Abstract no: 685.
48. Spinnato II JA, Freire S, Pinto e Silva JL, Cunha Rudge MV, Martins-Costa S, Koch MA, et al. Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstetrics & Gynecology 2007;110(6):1311-8.
49. Spinnato II JA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, Koch MA, et al. Antioxidant supplementation and premature rupture of the membranes: a planned secondary analysis. American Journal of Obstetrics and Gynecology 2008; Vol. 199, issue 4:433.e1-433.e8.
50. Villar J, Purwar M, Merialdi M, Zavaleta N, Ngoc N, Anthony J, et al. Effect of vitamin C & E supplementation of pregnant women at risk of preeclampsia plus low nutritional status: the WHO trial. Hypertension in Pregnancy 2008; Vol. 27, issue 4:501.
51. Villar J, Purwar M, Merialdi M, Zavaleta N, Thi Nhu Ngoc N, Anthony J, et al. World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG: an international journal of obstetrics and gynaecology 2009; Vol. 116, issue 6:780-8.
52. Villar J, Purwar M, Merialdi M, Zavaleta N, Tien NN, Anthony J. WHO randomized trial of vitamin C and E supplementation among women at high risk for preeclampsia and nutritional deficiency. American Journal of Obstetrics and Gynecology 2007; Vol. 197, issue 6 Suppl 1:S4, Abstract no: 8.
53. Fraser W, Xiong X, Poston L, Shennan A. Bi-national randomized controlled trial of vitamin c and e supplementation of pregnancy [abstract]. Hypertension in Pregnancy 2002;21(Suppl 1):43.
54. Xu H, Perez-Cuevas R, Xiong X, Reyes H, Julien P, Smith G, et al. A international trials of vitamins C and E in the prevention of preeclampsia (INTAPP trial). American Journal of Obstetrics and Gynecology 2009; Vol. 201, issue 6 Suppl 1:S2.
55. Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, Julien P, et al. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). American Journal of Obstetrics and Gynecology 2010; Vol. 202, issue 3:239.e1-239.e10.
56. Bolisetty S, Naidoo D, Lui K, Koh TH, Watson D, Whitehall J. Antenatal supplementation of antioxidant vitamins to reduce the oxidative stress at delivery - a pilot study. Early Human Development 2002;67:47-53.
57. Clark J, Craig L, McNeill G, Smith N, Norrie J, Devereux G. A novel dietary intervention to optimize vitamin E intake of pregnant women to 15 mg/day. Journal of the Academy of Nutrition and Dietetics 2012;112(2):297-301.
58. Lietz G, Henry CJK, Mulokozi G, Mugyabuso JKL, Ballart A, Ndossi GD, et al. Comparison of the effects of supplemental red palm oil and sunflower oil on maternal vitamin A status. American Journal of Clinical Nutrition 2001;74:501-9.
59. Moldenhauer J, Guo S, Liang R, Prada J. Dietary intake levels of the antioxidants vitamin c and vitamin e are adequately achieved with standard prenatal vitamin supplementation in high risk pregnancy groups [abstract]. American Journal of Obstetrics and Gynecology 2002;187(6 Pt 2):S99.
60. Sezikawa A. Antioxidant supplementation in pregnant women with low antioxidant status. ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 21 June 2007] 2007.
61. Wibowo N, Purwosunu Y, Sekizawa A, Farina A, Idriansyah L, Fitriana I. Antioxidant supplementation in pregnant women with low antioxidant status. Journal of Obstetrics and Gynaecology Research 2012;38(9):1152-61. [PUBMED: 22563751]
62. Tan YL, Han BF, Cheng YZ, Lin ML, Huang JX, Hou SY, et al. The prevention of vitamin E in severe pregnancy induced hypertension syndrome. Journal of Practice Obstetrics and Gynecology 1997;13(6):313-4.
63. Basaran A, Basaran M, Topatan B. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstetrical & Gynecological Survey 2010;65(10):653-67.
64. Bendich A, Machlin LJ. The safety of oral intake of vitamin E: data from clinical studies from 1986-1991. In: Packer L, Fuchs J editor(s). Vitamin E in Health and Disease. New York: Marcel Dekker, 1993:411-6.
65. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD007176]
66. Bjelakovic G, Nikolova D, Gluud C. Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?. PLoS One 2013;8(9):e74558.
67. Conde-Agudelo A, Romero R, Kusanovic JP, Hassan SS. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: A systematic review and metaanalysis. American Journal of Obstetrics and Gynecology 2011;204(6):503.e1-503.e12.
68. Devaraj S, Adams-Huet B, Fuller CJ, Jialal I. Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation. Arteriosclerosis, Thrombosis and Vascular Biology 1997;17(10):2273-9.
69. McMaster University. GRADEpro. [Computer program on www.gradepro.org]. Version 2015. McMaster University, 2014.
70. Gross SJ, Landaw SA. The effect of vitamin E on red cell hemolysis and bilirubinaemia. Annals of the New York Academy of Science 1982;393:315-22.
71. Hanson U, Persson B. Outcome of pregnancies complicated by type 1 insulin-dependent diabetes in Sweden: acute pregnancy complications, neonatal mortality and morbidity. American Journal of Perinatology 1993;10(4):330-3.
72. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
73. Incebiyik A, Vural M, Camuzcuoglu A, Camuzcuoglu H, Hilali NG, Taskin A, et al. Comparison of tissue prolidase enzyme activity and serum oxidative stress level between pregnant women with placental abruption and those with a healthy pregnancy. Archives of Gynecology and Obstetrics 2015;291(4):805-9.
74. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington DC: National Academy Press, 2000.
75. Johnson L, Bowen FW Jr, Abbasi S, Herrmann N, Weston M, Sacks L, et al. Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birthweight 1, 500 grams or less. Pediatrics 1985;75:619-38.
76. Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. European Journal of Obstetrics & Gynecology and Reproductive Biology 2000;92:35-43.
77. NHMRC Nutrient Reference Values for Australia and New Zealand. Canberra, Australia: Commonwealth of Australia, 2006.
78. Packer JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979;278:737-8.
79. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
80. Roberts DCK. Vitamin E. In: Truswell AS, Dreosti IE, English RM, Palmer N, Rutihauser IHE editor(s). Recommended Nutrient Intakes, Australian Papers. Sydney: Australian Professional Publications, 1990:158-73.
81. Rumbold A, Duley L, Crowther C, Haslam R. Antioxidants for preventing pre-eclampsia. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD004227.pub3]
82. Rumbold AR, Crowther CA. Vitamin C supplementation in pregnancy. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD004072.pub2]
83. Saugstad OD. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatric Research 1988;23:143-50.
84. Saugstad OD. Update on oxygen radical disease in neonatology. Current Opinion in Obstetrics and Gynecology 2001;13(2):147-53.
85. Schunemann HJ. GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice [GRADE: Von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 2009;103(6):391-400.
86. Sharma SC, Walzman M, Bonnar J, Molloy A. Blood ascorbic acid and histamine levels in patients with placental bleeding. Human Nutrition. Clinical Nutrition 1985;39(3):233-8.
87. Sharma SC, Bonnar J, Dóstalóva L. Comparison of blood levels of vitamin A, beta-carotene and vitamin E in abruptio placentae with normal pregnancy. International Journal for Vitamin and Nutrition Research 1986;56(1):3-9.
88. Woods JR Jr, Plessinger MA, Miller RK. Vitamins C and E: missing links in preventing preterm premature rupture of membranes?. American Journal of Obstetrics and Gynecology 2001;185(1):5-10.
89. Rumbold A, Crowther CA. Vitamin E supplementation in pregnancy. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD004069.pub2]